Lacadman, Mark Jeo A.
HRN: 23-52-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/19/2024
08/26/2024
PO
1ml
QID
Mouth Sores
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Eye, Ear, Nose, Throat, & MouthProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes